Optimal Medical Therapy for Non–ST-Segment–Elevation Acute Coronary Syndromes
Authors:
- Andrew T. YanAYAndrew T. Yan
- Raymond T. YanRYRaymond T. Yan
- Cindy H. LeeCLCindy H. Lee
- Mary TanMTMary Tan
- Carolyn BaerCBCarolyn Baer
- Petr PolasekPPPetr Polasek
- David H. FitchettDFDavid H. Fitchett
- Anatoly LangerALAnatoly Langer
- Shaun G. GoodmanSGShaun G. Goodman
- for the Canadian Acute Coronary Syndromes Registry II InvestigatorsFIfor the Canadian Acute Coronary Syndromes Registry II Investigators
Open Access
- 1 September 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 3 (5) , 530-537
Abstract
Background— Acute coronary syndrome (ACS) patients in the highest risk categories are least likely to receive evidence-based treatments (EBTs). We sought to determine why physicians do not prescribe EBTs for patients with non–ST-segment–elevation ACSs and the factors determining use of these treatments after 1 year. Methods and Results— One thousand nine hundred fifty-six non–ST-segment-elevation ACS patients were enrolled in the prospective, multicenter Canadian ACS registry II between October 2002 and December 2003. Each patient's physician gave reasons why guideline-indicated medication(s) was not prescribed during hospitalization. Medication use and reason(s) for discontinuation after 1 year were obtained by telephone interview of the patients. The commonest reason for not prescribing EBTs was “not high-enough risk” or “no evidence/guidelines to support use.” However, Global Registry of Acute Coronary Events scores of patients not treated for this reason were often similar to or higher than those of patients prescribed such treatment. After 1 year, 77% of patients not on optimal ACS treatment at discharge remained without optimal treatment, and overall antiplatelet, β-blocker, and angiotensin-converting enzyme inhibitor use declined. Approximately one third of patients not taking EBTs had stopped their medication without instruction from their doctor. Conclusions— Nonprovision of EBTs may be due to subjective underestimation of patient risk and hence, likely treatment benefit. Oversights in care delivery were also apparent. Objective risk stratification, combined with efforts to ensure provision and adherence to EBTs, should be encouraged.Keywords
This publication has 27 references indexed in Scilit:
- Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary EventsHeart, 2008
- Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After DischargeJACC, 2008
- The association between guideline-based treatment instructions at the point of discharge and lower 1-year mortality in Medicare patients after acute myocardial infarction: The American College of Cardiology's Guidelines Applied in Practice (GAP) initiative in MichiganAmerican Heart Journal, 2007
- ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial InfarctionJACC, 2007
- Patterns of Guideline Adherence and Care Delivery for Patients with Unstable Angina and Non–ST-segment Elevation Myocardial Infarction (From the CRUSADE Quality Improvement Initiative)The American Journal of Cardiology, 2006
- Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE)Heart, 2006
- The influence of risk status on guideline adherence for patients with non–ST-segment elevation acute coronary syndromesAmerican Heart Journal, 2006
- The American Heart Association get with the guidelines programAmerican Heart Journal, 2004
- Impact of Combination Evidence-Based Medical Therapy on Mortality in Patients With Acute Coronary SyndromesCirculation, 2004
- Under utilisation of evidence-based treatment partial explanation for the unfavourable prognosis in diabetic patients with acute myocardial infarctionEuropean Heart Journal, 2003